Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study

Authors

Pu Wang (ORCID: https://orcid.org/0000-0002-1234-309X)
Yanmei Si (ORCID: https://orcid.org/0000-0001-8424-8238)
Jun Xu (ORCID: https://orcid.org/0000-0002-6080-118X)
Qifa Liu
Fen Huang (ORCID: https://orcid.org/0000-0001-5064-2528)
Rongtao Xue (ORCID: https://orcid.org/0000-0001-7269-4708)
Xiang Yao (ORCID: https://orcid.org/0000-0003-3290-8702)
Zhiping Fan (ORCID: https://orcid.org/0000-0002-3652-3618)
Kaibo Yang (ORCID: https://orcid.org/0009-0002-7707-0288)
Yingying Gu (ORCID: https://orcid.org/0000-0001-9004-1823)
Xuan Li (ORCID: https://orcid.org/0000-0003-1052-4222)
Xiaofang Li
Chen Ye (ORCID: https://orcid.org/0000-0002-0048-6974)
Na Xu (ORCID: https://orcid.org/0000-0002-2040-7639)
Zhixiang Wang (ORCID: https://orcid.org/0000-0002-6364-6891)
Jing Du (ORCID: https://orcid.org/0000-0002-9488-8092)
Jing Sun (ORCID: https://orcid.org/0000-0002-4345-0293)
Hui Liu (ORCID: https://orcid.org/0009-0003-3273-6979)

Institutions

First Affiliated Hospital of Guangzhou Medical University (CN)
Nanfang Hospital (CN)
Beijing Hospital (CN)
Southern Medical University (CN)
Guangzhou Medical University (CN)

Publication Details

Journal: BMC Medicine
Published: 2025-08-26
DOI: https://doi.org/10.1186/s12916-025-04336-z
Citations: 3
Primary Topic: Clostridium difficile and Clostridium perfringens research
Type: article
Field-Weighted Citation Impact: 4.19

Funders

National Natural Science Foundation of China
China Postdoctoral Science Foundation
State Key Laboratory of Ophthalmology
National Key Research and Development Program of China
Basic and Applied Basic Research Foundation of Guangdong Province

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study

Pu Wang, Yanmei Si, Jun Xu, Qifa Liu et al.

Aug 26, 2025

3 citations

BMC Medicine

Clostridium difficile and Clostridium perfringens research

4.19

article

Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study

Pu Wang, Yanmei Si, Jun Xu, Qifa Liu, Fen Huang, Rongtao Xue, Xiang Yao, Zhiping Fan, Kaibo Yang, Yingying Gu, Xuan Li, Xiaofang Li, Chen Ye, Na Xu, Zhixiang Wang, Jing Du, Jing Sun, Hui Liu

August 26, 2025article en

3 citations

Abstract

No abstract available for this paper.

BMC MedicineVol. 23(1)

First Affiliated Hospital of Guangzhou Medical University (CN), Nanfang Hospital (CN), Beijing Hospital (CN), Southern Medical University (CN), Guangzhou Medical University (CN)

National Natural Science Foundation of China, China Postdoctoral Science Foundation, State Key Laboratory of Ophthalmology, National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province

Good health and well-being

Openalex Percentile: Top 6%

Clostridium difficile and Clostridium perfringens research

4.19

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study — Pu Wang, Yanmei Si, et al. · BMC Medicine (2025) | TGRS Research Map | TGRS